Capricor Therapeutics (CAPR)
26.71
-1.24 (4.44%)
Upcoming Events
Latest Headlines
Form 4 CAPRICOR THERAPEUTICS, For: May 26 Filed by: Maurer Michael T
May 28, 2026 9:55 PM - SEC Filing
Form 3 CAPRICOR THERAPEUTICS, For: May 25 Filed by: Maurer Michael T
May 28, 2026 9:52 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: May 18 Filed by: Bergmann Anthony
May 19, 2026 4:15 PM - SEC Filing
Form 144/A CAPRICOR THERAPEUTICS, Filed by: Musket David B
May 19, 2026 2:41 PM - SEC Filing
Form 144 CAPRICOR THERAPEUTICS, Filed by: Musket David B
May 19, 2026 11:40 AM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: May 13 Filed by: Litvack Frank
May 14, 2026 5:00 PM - SEC Filing
Form 10-Q CAPRICOR THERAPEUTICS, For: Mar 31
May 13, 2026 5:21 PM - SEC Filing
B.Riley Reiterates Buy Rating on Capricor Therapeutics (CAPR)
May 13, 2026 4:15 AM - StreetInsider
Capricor Therapeutics (CAPR) Misses Q1 EPS by 7c
May 12, 2026 4:13 PM - StreetInsider
Form 8-K CAPRICOR THERAPEUTICS, For: May 12
May 12, 2026 4:07 PM - SEC Filing
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026 4:05 PM - Globe NewsWire
Capricor sues NS Pharma over Duchenne therapy distribution deal
May 8, 2026 7:15 AM - StreetInsider
Form 8-K CAPRICOR THERAPEUTICS, For: May 07
May 7, 2026 4:41 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Krasney Karen
May 4, 2026 4:30 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Bergmann Anthony
May 4, 2026 4:30 PM - SEC Filing
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
May 4, 2026 4:05 PM - Globe NewsWire
Capricor presents HOPE-3 trial data at neurology meeting
April 22, 2026 9:02 AM - StreetInsider
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
April 22, 2026 9:02 AM - Globe NewsWire
Form ARS CAPRICOR THERAPEUTICS, For: Dec 31
April 10, 2026 5:18 PM - SEC Filing
Form DEF 14A CAPRICOR THERAPEUTICS, For: Jun 04
April 10, 2026 4:31 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: Apr 02 Filed by: Sabar Karimah Es
April 3, 2026 5:00 PM - SEC Filing
Form 144 CAPRICOR THERAPEUTICS, Filed by: Sabar Karimah Es
April 2, 2026 4:24 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Sabar Karimah Es
April 1, 2026 8:00 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Krasney Karen
April 1, 2026 8:00 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Bergmann Anthony
April 1, 2026 8:00 PM - SEC Filing
Form PRE 14A CAPRICOR THERAPEUTICS, For: May 22
March 31, 2026 5:24 PM - SEC Filing
Form 144 CAPRICOR THERAPEUTICS, Filed by: Krasney Karen
March 31, 2026 4:24 PM - SEC Filing
Form 144 CAPRICOR THERAPEUTICS, Filed by: Bergmann Anthony
March 31, 2026 4:23 PM - SEC Filing
Form 144 CAPRICOR THERAPEUTICS, Filed by: Sabar Karimah Es
March 31, 2026 4:23 PM - SEC Filing
Form 4 CAPRICOR THERAPEUTICS, For: Dec 30 Filed by: Krasney Karen
March 27, 2026 7:15 PM - SEC Filing
Form 10-K CAPRICOR THERAPEUTICS, For: Dec 31
March 17, 2026 5:01 PM - SEC Filing
Capricor Therapeutics (CAPR) PT Raised to $58 at Piper Sandler
March 13, 2026 9:02 AM - StreetInsider
Capricor Therapeutics (CAPR) PT Raised to $63 at B.Riley
March 13, 2026 8:27 AM - StreetInsider
Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald After Q4 Result
March 13, 2026 7:30 AM - StreetInsider
Capricor Therapeutics (CAPR) Misses Q4 EPS by 11c
March 12, 2026 4:17 PM - StreetInsider
Form 8-K CAPRICOR THERAPEUTICS, For: Mar 12
March 12, 2026 4:01 PM - SEC Filing
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 12, 2026 4:01 PM - Globe NewsWire
Capricor reports positive HOPE-3 trial results for Duchenne therapy
March 12, 2026 9:02 AM - StreetInsider
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
March 12, 2026 9:01 AM - Globe NewsWire
Form 8-K CAPRICOR THERAPEUTICS, For: Mar 10
March 10, 2026 11:01 AM - SEC Filing
Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR) as FDA review resumed
March 10, 2026 10:37 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
March 10, 2026 10:05 AM - StreetInsider
FDA sets new PDUFA date for Capricor's Deramiocel therapy
March 10, 2026 9:25 AM - StreetInsider
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
March 10, 2026 9:25 AM - Globe NewsWire
Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12
March 9, 2026 8:30 AM - Globe NewsWire
uniQure stock surges 36% on FDA official’s departure
March 9, 2026 7:57 AM - StreetInsider
Truist on Head of CBER at FDA Exit: 'we anticipate a positive stock reaction for IRON CAPT RGNX QURE'
March 9, 2026 7:46 AM - StreetInsider
Full Article List
